[Myelo-meningoradiculitis secondary to cytomegalovirus infection in a non immunocompromised patient. Treatment with foscarnet].
Rogeaux
O
O
Bedos
J P
JP
Wolf
M
M
Vachon
F
F
D000293:Adolescent; D000998:Antiviral Agents / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000188:drug therapy / Q000209:etiology*; D003586:Cytomegalovirus Infections / Q000150:complications* / Q000188:drug therapy; D017245:Foscarnet; D006801:Humans; D008297:Male; D008587:Meningitis, Viral / Q000188:drug therapy / Q000209:etiology*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D011843:Radiculopathy / Q000188:drug therapy / Q000209:etiology*
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid
Myélo-méningo-radiculite. Secondaire à une infection à CMV chez un sujet non immunodéprimé. Traitement par foscarnet.